The Role of Clinical and Cost Information in Medicaid Pharmacy Benefit Decisions: Experience in Seven States
This policy brief provides perspective on the potential for using comparative effectiveness research in Medicaid pharmacy programs by looking at seven states to determine how they currently evaluate relative clinical and cost information about prescription drugs when making coverage decisions for their Medicaid pharmacy benefits. The brief was prepared by researchers at the Foundation’s Kaiser Commission on Medicaid and the Uninsured and Avalere Health.
Policy Brief (.pdf)
also of interest
- Long-Term Services and Supports in the Financial Alignment Demonstrations for Dual Eligible Beneficiaries
- Washington's Managed FFS Demonstration to Integrate Care and Align Financing for Dual Eligible Beneficiaries
- Faces of Dually Eligible Beneficiaries: Profiles of People with Medicare and Medicaid Coverage